Hongqian Zhu
No. 83, Zhongshan East Road, Nanming District
Guiyang, 550002, China
Guiyang, 550002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Dual inhibition of tubulin and DNMT by the novel letermovir derivative H62 blocks leukemia.
Journal: Biochemical pharmacology
Published: April 21, 2026
Lactate-mediated macrophage polarization promotes splenomegaly in acute erythroleukemia.
Journal: Cell death & disease
Published: July 29, 2025
Extracellular vesicle-mediated regulation of imatinib resistance in chronic myeloid leukemia via the miR-629-5p/SENP2/PI3K/AKT/mTOR axis.
Journal: Hematology (Amsterdam, Netherlands)
Published: July 26, 2024
Safety and efficacy of flumatinib as later-line therapy in patients with chronic myeloid leukemia.
Journal: Haematologica
Published: December 30, 2023
Patient Versus Physician Perspective in the Management of Chronic Myeloid Leukemia During Treatment with Tyrosine Kinase Inhibitors.
Journal: Oncology and therapy
Published: September 01, 2023
miR-621 May Suppress Cell Proliferation via Targeting lncRNA SNHG10 in Acute Myeloid Leukemia.
Journal: Cancer management and research
Published: June 26, 2020
LncRNA VPS9D1-AS1 promotes cell proliferation in acute lymphoblastic leukemia through modulating GPX1 expression by miR-491-5p and miR-214-3p evasion.
Journal: Bioscience reports
Published: September 26, 2019
Leucine-Rich Alpha-2-Glycoprotein1 Gene Interferes with Regulation of Apoptosis in Leukemia KASUMI-1 Cells.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: November 21, 2018
miR-126 promotes the growth and proliferation of leukemia stem cells by targeting DNA methyltransferase 1.
Journal: International journal of clinical and experimental pathology
Published: May 03, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026